Center-Authored Papers

Filters: Author is Martino, Silvana  [Clear All Filters]
D
Dueck AC, Reinholz MM, Geiger XJ, Tenner K, Ballman K, Jenkins RB, Riehle D, Chen B, McCullough AE, Davidson NE et al..  2013.  Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(20):5798-807. Abstract
G
Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin WJ, Martino S, Albain KS.  2008.  Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(8):1223-30. Abstract
Goodwin WJ, Green SJ, Moinpour CM, Bearden JD, Giguere JK, Jiang CS, Lippman SM, Martino S, Albain KS.  2008.  Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(10):1650-6. Abstract
L
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
M
Moore HCF, Unger JM, Phillips K-A, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS et al..  2015.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.. The New England journal of medicine. 372(10):923-32. Abstract
P
Perez EA, Dueck AC, McCullough AE, Chen B, Geiger XJ, Jenkins RB, Lingle WL, Davidson NE, Martino S, Kaufman PA et al..  2013.  Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17):2115-22. Abstract